Premium
Metabolic syndrome: signs and symptoms running together
Author(s) -
Brady Tammy M.,
Parekh Rulan S.
Publication year - 2010
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2009.01288.x
Subject(s) - medicine , dyslipidemia , metabolic syndrome , kidney disease , disease , obesity , pediatrics , population , kidney transplantation , left ventricular hypertrophy , transplantation , blood pressure , environmental health
Brady TM, Parekh RS. Metabolic syndrome: signs and symptoms running together.
Pediatr Transplantation 2010: 14: 6–9. © 2010 John Wiley & Sons A/S. Abstract: Children with kidney disease are at increased risk of having several comorbidities such as obesity, dyslipidemia, hypertension, and impaired glucose tolerance, and patients with a constellation of these symptoms are considered to have the MS. Children with kidney disease, and ESRD in particular, are at increased CV risk, as are patients with the MS. To determine the impact MS has on a particularly vulnerable population of children, those who have received a kidney transplant, Wilson et al. explored the prevalence of MS and the association of MS with cardiac abnormalities among this subset of children. They found an overall high prevalence of MS among pediatric transplant recipients and that the risk of left ventricular hypertrophy was higher among children with MS after renal transplant compared to those without MS. Review of the most common definitions of MS and also the clinical implications are discussed. While there is no doubt that children with kidney disease have a high prevalence of CV risk factors and that these children are at risk for CV events early in life, whether the sum of the parts of MS confers increased risk over what is seen with individual risk factors that often run together remains to be seen.